Featured Research

from universities, journals, and other organizations

Asthma Researchers Present New Results, New Perspectives On The Disease

Date:
February 26, 2002
Source:
NIH/National Institute Of Allergy And Infectious Diseases
Summary:
Preliminary results of a long-term study show two new ways to reduce asthma severity in inner-city children. Researchers will present these results at the annual meeting of the American Academy of Allergy, Asthma, and Immunology (AAAAI), which takes place at the Hilton New York hotel on March 1-6.

February 25, 2002 -- Preliminary results of a long-term study show two new ways to reduce asthma severity in inner-city children. Researchers will present these results at the annual meeting of the American Academy of Allergy, Asthma, and Immunology (AAAAI), which takes place at the Hilton New York hotel on March 1-6.

The six-year investigation is part of the ongoing efforts of the Inner-City Asthma Study, a program supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Environmental Health Sciences (NIEHS). Established in 1991, the Inner-City Asthma Study has involved 12 centers nationwide and about 3,000 children so far. Its primary aim is to find out why asthma disproportionately affects inner-city children and to test new ways to treat the disease.

Since 1996, the current Inner-City Asthma Study has been investigating two methods to improve the health of inner-city children with asthma. The first method, called a physician feedback intervention, involves periodic reports to the child’s doctor about the status of the child’s asthma. These reports, generated from bi-monthly phone interviews with parents, recommend changes in the child’s treatment regimen if warranted. The second method, called an environmental intervention, involves identifying and removing asthma triggers such as cigarette smoke or cockroaches from the child’s home.

Initial data suggest these interventions effectively reduce emergency room visits and asthma symptoms for inner-city children. Researchers Wayne J. Morgan, M.D., of the University of Arizona, and Herman E. Mitchell, Ph.D., of Rho Inc., in Chapel Hill, N.C., will present the results at a symposium on Monday, March 4 at 12:15 p.m. Journalists are welcome to attend.

A New Perspective on Asthma

Another symposium at the AAAAI meeting will explore the idea that asthma consists of several subtypes. These include allergic asthma, exercise-induced asthma, asthma caused by bacterial and fungal infections, asthma in the elderly, and more. Each behaves somewhat differently, is triggered differently, and may respond to different treatments or interventions.

“Asthma is usually considered a single disease, but it may be more helpful to doctors and more productive for researchers to think of asthma as many related diseases,” says Ken Adams, Ph.D., chief of NIAID’s asthma and inflammation section. Dr. Adams has brought together twelve specialists in various sub-types of asthma. They will share their clinical experiences and research results on Friday, March 1 at 8:45 a.m.

Current asthma treatments such as inhaled corticosteroids and beta agonists are non-specific: They treat only the general effect of asthma - an inflamed or constricted airway - and not any of the underlying causes. Dr. Adams hopes this symposium might spur interest in research that would lead to more specific therapies that target the various causes of asthma. In addition, the presentations should help clinicians understand the subtypes of the disease so that they can better diagnose and manage a patient’s asthma.

NIAID is a component of the National Institutes of Health (NIH). NIAID supports basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, tuberculosis, malaria, autoimmune disorders, asthma and allergies.

Press releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.


Story Source:

The above story is based on materials provided by NIH/National Institute Of Allergy And Infectious Diseases. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Institute Of Allergy And Infectious Diseases. "Asthma Researchers Present New Results, New Perspectives On The Disease." ScienceDaily. ScienceDaily, 26 February 2002. <www.sciencedaily.com/releases/2002/02/020226073819.htm>.
NIH/National Institute Of Allergy And Infectious Diseases. (2002, February 26). Asthma Researchers Present New Results, New Perspectives On The Disease. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2002/02/020226073819.htm
NIH/National Institute Of Allergy And Infectious Diseases. "Asthma Researchers Present New Results, New Perspectives On The Disease." ScienceDaily. www.sciencedaily.com/releases/2002/02/020226073819.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins